Posts Tagged ‘Merck & Co. Inc. (MRK)’

isak55/Shutterstock.com

Madison Street Partners Reshuffles Its Portfolio and Bets on ETFs; See Its Top Stock Picks

Steven Owsley‘s Madison Street Partners recently filed its 13F form for the second quarter with the SEC. There has been significant changes in......(read more)
cheerful pharmacist chemist woman standing in pharmacy drugstore

Pfizer And Merck Earnings Previews: Mega-Cap Pharmas Try To Stem Revenue Erosion

This article is temporarily removed from Insider Monkey....(read more)
Irving Kahn

Pfizer Inc. (PFE), Merck & Co., Inc. (MRK), Citigroup Inc (C) Top Kahn Brothers’ Portfolio

Kahn Brothers Advisors LLC is an Investment Advisor company providing brokerage and money management services to clients. An old member of the NY Stock......(read more)
Alex Denner Sarissa Capital

Ariad Pharmaceuticals, Inc. (ARIA), Amgen, Inc. (AMGN): How Sarissa Capital’s Top Picks Beat the Market

Headquartered in Connecticut, Sarissa Capital Management was founded by Alexander J. Denner in 2012. Prior to this, Mr. Denner worked as a portfolio manager......(read more)
Irving Kahn

Pfizer Inc. (PFE) Helped Kahn Brothers Beat the Market Despite BlackBerry Ltd (BBRY) Losses

Kahn Brothers, managed by Alan Kahn and Thomas Kahn managed to beat the market in the first quarter of 2015, a period during which the fund’s co-founder......(read more)
superconductor

Superconductor Technologies, Inc. (SCON), Pfizer Inc. (PFE), ACADIA Pharmaceuticals Inc. (ACAD): Sabby Capital’s Latest Moves in Healthcare Sector

Hal Mintz‘s Sabby Capital has initiated a passive stake in Superconductor Technologies, Inc. (NASDAQ:SCON) according to a schedule 13G form filed......(read more)
Pfizer Inc. (NYSE:PFE)

Hedge Funds Are Crazy About These Five Dow Jones Dividend Leaders

  Tracking the activity of hedge funds is a great way to identify profitable investments that will help you beat the market. Hence, here at Insider......(read more)
Irving Kahn

Kahn Brothers’ Top Picks to Close 2014, as Founder Irving Kahn Passes at 109

Irving Kahn, the oldest active investor on Wall Street, died this week at age 109. The successful manager is succeeded by his sons, who he co-founded ......(read more)
Hedge Fund Managers

10 Most Popular Healthcare Stocks Among Hedge Funds

With the business of analyzing and compiling the data of our 737 tracked hedge funds’ latest 13F filings behind us, we’re ready to start sharing some......(read more)
Covalent Capital

General Motors Company (GM), MGM Resorts International (MGM), Citigroup Inc (C): Covalent Capital Partners’ Top Picks Heading Into 2015

Robert Hockett’s Covalent Capital Partners has filed a 13F with the SEC, declaring its long equity positions at the end of 2014. Save for their ordering......(read more)
Dmitry Balyasny

Funds Reveal New Positions in Peabody Energy Corporation (BTU), BIND Therapeutics Inc (BIND)

Two of our tracked funds have recently revealed in filings with the SEC that they’ve taken large new passive positions in a couple of stocks. Hal Mintz......(read more)
Merck MRK

Steven Wishnia’s Highland Capital Management Discloses Top 3 Picks For Q4

In its latest 13F form filed with the U.S. Securities and Exchange Commission, Steven Wishnia’s Highland Capital Management LLC disclosed its top......(read more)
Merck & Co., Inc. (NYSE:MRK)

Merck & Co., Inc. (MRK) To absorb $1.1 Billion In Net debt On Cubist Pharmaceuticals Inc. (CBST) Acquisition

Merck & Co., Inc. (NYSE:MRK) is looking forward to expanding its portfolio of drugs mostly administered in the hospital settings for bacterial infections......(read more)
Visa, Mastercard, is MA a good stock to buy, is V a good stock to buy, Ed McLaughlin

Cramer’s Top Picks:Visa Inc. (V), MasterCard Inc. (MA) and Merck & Co.Inc. (MRK)

Heading into the close of the year, Visa Inc. (NYSE:V) and MasterCard Inc. (NYSE:MA) remain CNBC’s Jim Cramer top picks in the payment sector as both......(read more)
Bristol Myers Squibb Co. (NYSE:BMY)

Bristol-Myers Squibb Co (BMY) Sues Merck & Co., Inc. (MRK) Over Cancer Drug, Position Strong

Bristol-Myers Squibb Co (NYSE:BMY) along with Ono Pharmaceutical launched a lawsuit against Merck & Co., Inc. (NYSE:MRK) last Thursday, claiming that......(read more)
Warren Buffett and Billionaires

Hedge Fund News: Warren Buffett, Phil Falcone & Baupost Group

Warren Buffett betrays America (SLTrib) It must have been a bitter moment for President Barack Obama when he got the news that his favorite economic guru......(read more)
Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (PFE) To Sweeten Bid for Astrazeneca plc (ADR) (AZN): Frost & Sullivan

Ranjith Gopinathan, who is a program manager, life sciences and healthcare practice at Frost & Sullivan during an interview on CNBC said that while......(read more)
Pfizer Inc. (NYSE:PFE)

How Pharma Majors like Pfizer Inc. (PFE), Johnson & Johnson (JNJ) And Merck & Co. Inc. (MRK) Are Responding To Alzheimer?

CNBC’s Meg Tirrell reported on the popular “Squawk Box” program that patients suffering from Alzheimer disease in U.S and across the globe are......(read more)
Schlumberger Limited. (NYSE:SLB)

Beech Hill Partners Top Five Holdings at the End of March

Beech Hill Partners, led by Paul Cantor, Joseph Weiss, and Will Wurm, is a traditional boutique fund that was established as a privately owned investment......(read more)
Amgen, Inc. (NASDAQ:AMGN)

Stuart Weisbrod’s Iguana Healthcare Management Is Fond of These Stocks

New York City-based Iguana Healthcare Management was founded by Stuart Weisbrod in 2010. The fund invests in pharmaceuticals, biotechnology, medical devices......(read more)
Alex Denner Sarissa Capital

Activist Alex Denner’s Sarissa Capital Bets on Ariad Pharmaceuticals Inc (ARIA), Quest Diagnostics Inc (DGX) & Others

Alex Denner’s Sarissa Capital disclosed its holdings in its latest and first 13F filings. The hedge fund has invested $267.02 million in equity portfolio......(read more)
Merck & Co., Inc. (NYSE:MRK)

Merck Restructuring Takes Hold

Merck restructuring: On Tuesday, Merck & Co., Inc. (NYSE:MRK) announced that it will fire 8,500 workers. Also, it publicized the implementation......(read more)
Merck & Co., Inc. (NYSE:MRK)

The Pharmaceutical Industry’s 10 Biggest R&D Budgets

Innovation is everything when it comes to the pharmaceutical sector. Behind those glorious 75%-plus gross margins associated with branded and patented......(read more)
Exelixis, Inc. (NASDAQ:EXEL)

AstraZeneca plc (ADR) (AZN), Johnson & Johnson (JNJ): Will the Exelixis, Inc. (EXEL) Hype Catch Up to Its Valuation?

The small patient pool for medullary thyroid cancer, or MTC, isn’t going to move the needle for a large pharmaceutical company. But Exelixis, Inc......(read more)
AstraZeneca plc (ADR) (NYSE:AZN)

AstraZeneca plc (ADR) (AZN), Merck & Co., Inc. (MRK), Endocyte, Inc. (ECYT): Three Things You Need to Know About This Big Pharma Deal

Two big pharmaceutical players on opposite sides of the Atlantic have forged yet another bond. Through the years, London-based drugmaker AstraZeneca plc......(read more)
Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (PFE), Merck & Co., Inc. (MRK), Johnson & Johnson (JNJ): Top Risk Factors for Heart Disease

Heart disease is the leading cause of death in the United States. In 2010, according to data from the Centers for Disease Control and Prevention, 597,......(read more)
AstraZeneca plc (ADR) (NYSE:AZN)

Bristol Myers Squibb Co. (BMY), Merck & Co., Inc. (MRK): Is AstraZeneca plc (ADR) (AZN)’s Recent Acquisition Bigger Than Onyx?

AstraZeneca plc (ADR) (NYSE:AZN) may have missed out on acquiring the oncology platform of Onyx Pharmaceuticals, but it responded by pulling the trigger......(read more)
Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals Incorporated (VRTX), Merck & Co., Inc. (MRK), Rockwell Medical Inc (RMTI): Three Drug Classes That May Become Obsolete Within Three Years

There are few, if any, businesses in the world where innovation isn’t the top priority. Perhaps no sector, though, is more reliant on new ideas......(read more)
Merck & Co., Inc. (NYSE:MRK)

Merck & Co., Inc. (MRK), Akamai Technologies, Inc. (AKAM), Cyberonics, Inc. (CYBX): Next Leaders in Technology and Health Care

In an unusual divergence, stocks belonging to the defensive health care and cyclical technology spaces delivered some of the best responses to earnings......(read more)
Hospira, Inc. (NYSE:HSP)

Hospira, Inc. (HSP), Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK): Will This Biotech Approval Start a $100 Billion Trend?

Hospira, Inc. (NYSE:HSP) announced that the European Commission has approved its biosimilar version of Remicade from Johnson & Johnson (NYSE:JNJ......(read more)
Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (GILD), Merck & Co., Inc. (MRK): Everyone Wants a Piece of This Mega-Blockbuster

According to a recent Bloomberg report, Gilead Sciences, Inc. (NASDAQ:GILD) has chosen the legal route to protect sofosbuvir — its candidate for......(read more)
AT&T Inc.

AT&T Inc. (T), Verizon Communications Inc. (VZ): Are the Dogs of the Dow (.DJI) Still in the Race?

Will the Dogs beat the Dow in 2013 — or is their bark worse than their bite? The Dogs of the Dow strategy involve investing equal amounts into......(read more)
AstraZeneca plc (ADR) (NYSE:AZN)

Do Hedge Funds and Insiders Love AstraZeneca plc (ADR) (AZN)?

What’s a smart AstraZeneca plc (ADR) (NYSE:AZN) investor to do? At the moment, there are dozens of gauges investors can use to track Mr. Market......(read more)
Peregrine Pharmaceuticals (NASDAQ:PPHM)

Sanofi SA (ADR) (SNY), Bristol Myers Squibb Co. (BMY): Why Peregrine Pharmaceuticals (PPHM) Earnings Won’t Show Profits

Peregrine Pharmaceuticals (NASDAQ:PPHM) will release its latest quarterly report on Monday, and investors are under no illusions that the company will......(read more)
GlaxoSmithKline plc (ADR) (NYSE:GSK)

This Metric Says You Are Smart to Buy GlaxoSmithKline plc (ADR) (GSK)

What’s a smart GlaxoSmithKline plc (ADR) (NYSE:GSK) investor to do? In the financial world, there are many methods market participants can use......(read more)
Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (PFE), Merck & Co., Inc. (MRK): Two Reasons This Biotech Hardly Moved After a Successful Trial

Data doesn’t get much cleaner than this. Adding Esperion Therapeutics‘  ECT-1002 to Pfizer Inc. (NYSE:PFE)‘s Lipitor lowered bad LDL......(read more)
Eli Lilly & Co. (NYSE:LLY)

Eli Lilly & Co. (LLY), Amgen, Inc. (AMGN), Merck & Co., Inc. (MRK): Where We’re Headed

Over the past couple of months we’ve discussed many of the biggest risk factors associated with some of the leading causes of death in the United......(read more)
GlaxoSmithKline plc (ADR) (NYSE:GSK)

GlaxoSmithKline plc (GSK), Merck & Co. Inc. (MRK): HPV Vaccine for Boys Has “Good Start” in 1st Year

ATLANTA (AP) — When the HPV vaccine was first recommended for boys, health officials worried it would be an unusually hard sell. But a new report......(read more)
AbbVie Inc (NYSE:ABBV)

AbbVie Inc (ABBV): Are Hedge Funds Right About This Stock?

Is it smart to be bullish on AbbVie Inc (NYSE:ABBV)? Now, according to many investors, hedge funds are seen as overrated, outdated investment tools of......(read more)
Tyson Foods, Inc. (NYSE:TSN)

Tyson Foods, Inc. (TSN), Merck & Co., Inc. (MRK): Food Companies Suspend Growth Meds for Animals

Top beef producer Tyson Foods, Inc. (NYSE:TSN) has decided to stop buying cattle that are fed the growth additive Zilmax, produced by Merck & Co.,......(read more)
Zoetis Inc (NYSE:ZTS)

Pfizer Inc. (PFE), Zoetis Inc (ZTS), Merck & Co., Inc. (MRK), Sanofi SA (ADR) (SNY): 5 Reasons to Invest in Animal Health

In an attempt to further simplify its business and unlock shareholder value, Pfizer Inc. (NYSE:PFE) has been busy divesting itself of non-core assets......(read more)
Novartis AG (ADR) (NYSE:NVS)

Hedge Funds Are Buying Novartis AG (ADR) (NVS)

In the 21st century investor’s toolkit, there are dozens of methods market participants can use to monitor the equity markets. A couple of the best......(read more)
Gilead Sciences, Inc. (NASDAQ:GILD)

Vertex Pharmaceuticals Incorporated (VRTX), Merck & Co., Inc. (MRK): Gilead Sciences, Inc. (GILD) Races Against Competitors for an Oral Hepatitis-C Cure

The search for a hepatitis-C cure is one of the most active areas within biotechnology research and development. One of the company’s ushering in......(read more)
Merck & Co., Inc. (NYSE:MRK)

Tyson Foods, Inc. (TSN), Smithfield Foods, Inc. (SFD): Merck & Co., Inc. (MRK) Buried by Industry Beef

Like a pebble rolling downhill and starting an avalanche, the decision by Tyson Foods, Inc. (NYSE:TSN) to stop buying cattle fattened with the steroid......(read more)
Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (PFE), GlaxoSmithKline plc (ADR) (GSK), Merck & Co., Inc. (MRK): Which Pharmaceutical Giant Faces the Steepest Patent Cliff?

There are many undeniable tailwinds the pharmaceutical industry should capitalize on going forward, such as rising health-care costs and the aging U.S......(read more)
Eli Lilly & Co. (NYSE:LLY)

Eli Lilly & Co. (LLY), Merck & Co., Inc. (MRK), Sanofi SA (ADR) (SNY): Positive News for This Troubled Pharma Player

Eli Lilly & Co. (NYSE:LLY) recently rose nearly 3% following positive phase 3 results for cancer drug necitumumab. The company had previously halted......(read more)
Merck & Co., Inc. (NYSE:MRK)

Merck & Co., Inc. (MRK), Sony Corporation (ADR) (SNE): How the Dow Jones Industrial Average (.DJI)’s Oldest Company Got Started

On this day in economic and business history… The Dow Jones Industrial Average (INDEXDJX:.DJI) has 30 components, and all but one can trace their......(read more)
Eli Lilly & Co. (NYSE:LLY)

Hedge Funds Are Buying Eli Lilly & Co. (LLY)

Eli Lilly & Co. (NYSE:LLY) investors likely know every metric that’s typically discussed in relation to the healthcare giant, but we’ll......(read more)
Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (GILD), GlaxoSmithKline plc (ADR) (GSK): The Past, Present, and Future of HIV Treatments

HIV, the virus that causes AIDS, has become one of the world’s most devastating diseases since it was first recognized more than three decades ago......(read more)
The Medicines Company (NASDAQ:MDCO)

The Medicines Company (MDCO), Merck & Co., Inc. (MRK), Baxter International Inc. (BAX): Three Reasons to Like This Critical Care Company

The Medicines Company (NASDAQ:MDCO) is a mid-cap value stock that jumped by 21% in the last 12 months, trading at a 52-week price range of $20.04-$37.......(read more)
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!